Arca
Skip to content
Tools
Tools

Diffuse intrinsic pontine gliomas

Drug research and approvals for diffuse intrinsic pontine gliomas: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 22, 2026, 32 studies of diffuse intrinsic pontine gliomas are recruiting on ClinicalTrials.gov, and Health Canada has authorized 6 drug trials for it since 2013.

  • Recruiting worldwide: 32
  • Trials authorized in Canada: 6
  • FDA orphan approvals: 0
  • EU medicines: 0

Recruiting now

Newest posted first, of 32 recruiting on ClinicalTrials.gov ↗

Trials authorized in Canada

Newest first; search them all in Canada trials
Apr 5, 2024A multi-part, phase 1, multi-center, open-label, plus expansion clinical trial of an off-the-shelf neo-antigen heat shock protein vaccine (rhsc-dipgvax) in…Rhsc-dipgvax / Zalifrelimab / BalstilimabAnn and Robert H. Lurie Children's Hospital of ChicagoPending
Jul 6, 2023A pilot study of safety, tolerability, and immunological effects of survaxm in pediatric patients with progressive or relapsed medulloblastoma, high grade…Survaxm / LeukineChildrens Oncology GroupOngoing
Oct 4, 2022A phase I study of savolitinib in recurrent, progressive, or refractory medulloblastoma, high-grade glioma, diffuse intrinsic pontine glioma, and CNS tumors…SavolitinibPediatric Brain Tumour ConsortiumClosed
Oct 29, 2021A safety and feasibility study to evaluate blood brain barrier disruption using mr-guided focused ultrasound in combination with doxorubicin in treating…Definity (perflutren) / DoxorubicinInsightecPending
Oct 24, 2019H3.3k27m specific peptide vaccine combined with poly-iclc for the treatment of newly diagnosed HLA-A2+H3.3k27m positive diffuse intrinsic pontine glioma (DIPG)…H3.3K27M peptide vaccine, K27M/TT peptide / Hiltonol (poly-iclc) / Montanide…Pacific Pediatric Neuro-Oncology ConsortiumPending
Aug 29, 2013Advl1217, a phase 1 study of MK-1775 (ind#116459) concurrent with local radiation therapy for the treatment of newly diagnosed children with diffuse intrinsic…MK-1775Childrens Oncology GroupClosed

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.